Cargando…

Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa

Detalles Bibliográficos
Autores principales:	Molinelli, Elisa, Sapigni, Claudia, Simonetti, Oriana, Radi, Giulia, Gambini, Daisy, Maurizi, Andrea, Rizzetto, Giulio, D'Agostino, Giovanni Marco, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539466/ https://www.ncbi.nlm.nih.gov/pubmed/35716015 http://dx.doi.org/10.1111/dth.15645

Ejemplares similares

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2023)

Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild‐to‐moderate hidradenitis suppurativa: A retrospective study
por: Molinelli, Elisa, et al.
Publicado: (2022)

Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues
por: Molinelli, Elisa, et al.
Publicado: (2023)

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
por: Radi, Giulia, et al.
Publicado: (2021)

Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Reticulated acanthoma with sebaceous differentiation
por: Molinelli, Elisa, et al.
Publicado: (2021)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
por: Simonetti, Oriana, et al.
Publicado: (2021)

Is Exploration of Alternate Immune Pathways Needed in Hidradenitis Suppurativa? A Case of Atopic Dermatitis and Concurrent Hidradenitis Suppurativa Responding to Dupilumab
por: McCormack, Sean, et al.
Publicado: (2023)

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022)

New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing
por: Simonetti, Oriana, et al.
Publicado: (2021)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Should we be concerned about gastrointestinal‐related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real‐life study
por: Diotallevi, Federico, et al.
Publicado: (2022)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
por: Simonetti, Oriana, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2023)

Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review
por: De Simoni, Edoardo, et al.
Publicado: (2022)

A severe case of hidradenitis suppurativa
por: Cubas, Vanessa, et al.
Publicado: (2016)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021)

Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
por: Simonetti, Oriana, et al.
Publicado: (2022)

Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2022)

The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues
por: De Simoni, Edoardo, et al.
Publicado: (2023)

Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma
por: Lucarini, Guendalina, et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Peripheral ulcerative keratitis secondary to severe hidradenitis suppurativa
por: Dallalzadeh, Liane O., et al.
Publicado: (2022)

Bullous Pemphygoid and Novel Therapeutic Approaches
por: D’Agostino, Giovanni Marco, et al.
Publicado: (2022)

Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence
por: Hernández Montilla, Ignacio, et al.
Publicado: (2023)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016)

Management of severe hidradenitis suppurativa with biologic therapy and wide excision
por: Lim, Shi Yu Derek, et al.
Publicado: (2019)

Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
por: Krajewski, Piotr K., et al.
Publicado: (2022)

Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa)
por: Barrea, Luigi, et al.
Publicado: (2021)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
por: Marzano, A.V., et al.
Publicado: (2020)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Remission of chronic acne fulminans and severe hidradenitis suppurativa with targeted antibiotherapy
por: Duchatelet, Sabine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gamb9bbv36ufpnpe0m1a18ukhs